ストックスクリーナーアプリを入手
6.86
7.30%
-0.54
前日終値:
$7.40
開ける：
$7.4
24時間の取引高:
96,541
Relative Volume:
2.99
時価総額：
$115.47M
収益：
-
当期純損益:
$1.24B
株価収益率:
0.2693
EPS:
25.475
ネットキャッシュフロー:
$-31.80M
1週間 パフォーマンス:
-13.32%
1か月 パフォーマンス:
-32.01%
6か月 パフォーマンス:
-49.28%
1年 パフォーマンス:
-65.87%
1日の値動き範囲:
$6.51
$7.40
1週間の範囲:
$6.4155
$8.115
52週間の値動き範囲:
$6.4155
$31.50
Enlivex Ltd Stock (ENLV) Company Profile
Compare ENLV vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ENLV
Enlivex Ltd
|
6.86 | 115.47M | 0 | 1.24B | -31.80M | 25.48 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Enlivex Ltd Stock (ENLV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-03-02 | 繰り返されました | H.C. Wainwright | Buy |
Enlivex Ltd (ENLV) 最新ニュース
Enlivex Ltd. (ENLV) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Enlivex Treasury Portfolio Update: Rain Protocol Jumps Into Top Three Global Prediction Markets In League Table Following $100M In Additional Liquidity - 富途牛牛
Enlivex announces 1-for-15 reverse stock split effective Wednesday By Investing.com - Investing.com Nigeria
Enlivex Therapeutics outlines its immunotherapy approach as a clinical-stage biotech - ad-hoc-news.de
Enlivex (ENLV) Implements Reverse Stock Split - GuruFocus
symbol__ Stock Quote Price and Forecast - CNN
Enlivex Sets 1-for-15 Reverse Stock Split Ahead of July 9 Nasdaq Debut - TipRanks
Enlivex announces 1-for-15 reverse stock split effective Wednesday - Investing.com
Enlivex Announces 1-for-15 Reverse Stock Split Effective July 9, 2026 - The Manila Times
Enlivex (Nasdaq: ENLV) enacts 1-for-15 reverse split and cuts share count - Stock Titan
Enlivex to shrink share count 15-to-1 on July 9 as Nasdaq trading continues - Stock Titan
ENLV Q4 2025 Earnings: Staggering EPS Miss as Company Reports Significant LossesMargin Improvement Report - dars.gov.et
Discontinued operations of Enlivex Ltd. – DUS:1BT - TradingView
Preferred dividends of Enlivex Ltd. – DUS:1BT - TradingView
Enterprise value to revenue forward of Enlivex Ltd. – DUS:1BT - TradingView
Price to sales forward of Enlivex Ltd. – NASDAQ:ENLV - TradingView
Price to book forward of Enlivex Ltd. – NASDAQ:ENLV - TradingView
Enterprise value to EBIT forward of Enlivex Ltd. – NASDAQ:ENLV - TradingView
Enterprise value to EBITDA forward of Enlivex Ltd. – DUS:1BT - TradingView
Enlivex Ltd. Earnings and Revenue – DUS:1BT - TradingView
Enlivex Ltd. Actuals & Estimates (NASDAQ:ENLV) - TradingView
ENLV Forecast — Price Target — Prediction for 2027 - TradingView
1BT Forecast — Price Target — Prediction for 2027 - TradingView
ENLV Q4 2025 Earnings: Substantial EPS Miss as Clinical Expenses Outweigh ExpectationsRetail Earnings Report - dars.gov.et
Gate exchange lists Enlivex treasury asset RAIN token - Investing.com
Gate exchange lists Enlivex treasury asset RAIN token By Investing.com - Investing.com India
Enlivex’s Primary Treasury Asset RAIN Token set for Listing on Major Exchange Gate - TipRanks
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on Gate, One of the World's Largest Cryptocurrency Exchanges by Spot Trading Volume - The Manila Times
Enlivex (NASDAQ: ENLV) highlights RAIN listing on Gate and $1.14B treasury - Stock Titan
Enlivex Ltd. (ENLV) Edges Higher – Key Levels to WatchPrice Target - dars.gov.et
Enlivex Therapeutics Ltd (ENLV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Enlivex Therapeutics Ltd (ENLV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Enlivex Values RAIN Token Treasury at $1.14 Billion as of June 20, 2026 - TipRanks
Form 6K Enlivex Therapeutics Ltd For: 22 June By Investing.com - Investing.com South Africa
Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.14 Billion - The Manila Times
[6-K] Enlivex Ltd. Current Report (Foreign Issuer) | ENLV SEC FilingForm 6-K - Stock Titan
Enlivex Reports $1.14 Billion Value in RAIN Token Holdings as of June 20, 2026 - Quiver Quantitative
Enlivex says its RAIN token treasury is worth about $1.14 billion - Stock Titan
ENLV Stockweekly outlook with no verified hook - AD HOC NEWS
Enlivex Therapeutics Ltd (ENLV) Valuation: PE, PB & Fair Value Analysis - TradingKey
Enlivex Therapeutics Ltd (ENLV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Enlivex Therapeutics Ltd (ENLV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Enlivex Therapeutics Ltd (ENLV) Institutional Confidence - TradingKey
Enlivex Therapeutics Ltd (ENLV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Enlivex Therapeutics Ltd (ENLV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Enlivex Therapeutics Ltd (ENLV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ENLV Q4 2025 Earnings: Massive EPS Miss Highlights Challenging QuarterProfit Announcement - newsline.com
Enlivex Secures Australian Patent for Allocetra in Osteoarthritis Treatment - GuruFocus
Enlivex (ENLV) Slips Slightly as Stock Tests Key Support Near $0.63Positive Gamma - newsline.com
Enlivex receives Australian patent for osteoarthritis treatment - Investing.com
Enlivex receives Australian patent for osteoarthritis treatment By Investing.com - Investing.com Canada
Enlivex Ltd (ENLV) 財務データ
収益
当期純利益
現金流量
EPS
2.64%
大文字化:
|
ボリューム (24 時間):